Accordingly, a glioblastoma diagnosis is supposed to require, obviously, a setting of IDH-wildtype diffuse and astrocytic glioma, along with microvascular proliferation or necrosis, TERT promoter mutation, EGFR gene amplification or a gain of chromosome 7 and loss of chromosome 10. Here, EGFR is linked to glioblastoma.